Mohd Sajid Khan received his M.Sc. (2002) degree in Biotechnology from Pondicherry Central University, India; Ph.D. (2009) in Biotechnology from National Chemical Laboratory (NCL-CSIR) affiliated to Pune University, India. He then joined Integral University (2009) as Assistant Professor and became Associate Professor (2012-Till Date). He is the life member of Society of Biological Chemists, IISc Bangalore, India and Society of Free Radical Research, India. He is also annual member of World Society Interdisciplinary Anti-Aging Medicine (WOSIAM), Paris, France. He has been awarded as a Young Scientist in the field of Medical Nanotechnology by Council of Science & Technology, U.P. (2011), Joint CSIR-UGC Research Fellowship Award, Govt. of India, India (2001 & 2003), studentship by Department of Biotechnology, Govt. of India (2000-2002), got Best Business Plan presentation award in “Technology Entrepreneurship” conducted by CSIR, Govt. of India, and IIMB, India (2005). He is having three Indian patents and more than 35 international peer reviewed publications. He has fifteen years of research experience and has produced 4 Ph.D. with 6 six more Ph.D. scholars working under him. He has completed several projects from different national funding agencies. Presently, he has also been involved in an Indo-Russian project.
Mohd Sajid Khan Research Interests are controlled synthesis of enzyme mediated gold nanoparticles and their role in the drug delivery system against cancers. Controlled biosynthesis of inorganic nanoparticles has been a great challenge for researchers with perfect size and shape. Further, study of changes of 3D conformation of enzymes during interaction with GNPs is also going on. Eventually, bioconjugation of as-synthesized GNPs with anticancer drugs (such as Cisplatin, Doxorubicin, and Methotrexate) is also being studied. The nanomedicines have also been tested on rats (in vivo models) to check their toxicity, efficacy and potency.